
- Volume 0 0
Atorvastatin Reduces Incidence of Heart Attacks, Strokes, in Patients with Diabetes
The cholesterol-lowering drug atorvastatin (Lipitor) offers significant benefits guarding against heart attacks and strokes among patients with diabetes. The Collaborative Atorvastatin Diabetes Study (CARDS) is the largest study of statin use in patients with diabetes, involving more than 2800 patients with type 2 diabetes, no history of heart disease, and relatively low levels of cholesterol.
Among those patients taking atorvastatin, there was a 37% reduction in major cardiovascular events, and 48% fewer patients taking atorvastatin experienced strokes, compared with those taking placebo. In fact, atorvastatin proved so effective that the study was stopped 2 years early. This was the second time a study of atorvastatin was stopped early because of significant cardiovascular benefits. The number of cases of type 2 diabetes is increasing at an epidemic level, which researchers attribute to genetics, obesity, and lack of exercise.
Articles in this issue
about 22 years ago
Rural Pharmacy Chain Chooses ScriptPro Automationabout 22 years ago
System Improves Productivity, Drug Verificationabout 22 years ago
COMPOUNDING HOTLINEabout 22 years ago
Cardinal Introduces PatientPAK 340Babout 22 years ago
Obesity Is an Addiction, Researchers Sayabout 22 years ago
Scientists Seek to Understand How Fat Causes Cancerabout 22 years ago
Government Plans Attack on Obesityabout 22 years ago
Gene Discovery May Unlock Key to Obesity Syndromeabout 22 years ago
Consuming Fruit, Not Fat, Staves Off Weight GainRelated to this article








